Crizanlizumab in Sickle Cell Disease

N Engl J Med. 2017 May 4;376(18):1795-1796. doi: 10.1056/NEJMc1703162.

Authors

Zhou Yu^{1

2}, LeAnn Blankenship¹, Ishmael Jaiyesimi¹

Affiliations

¹ Oakland University William Beaumont School of Medicine, Rochester, MI
² zhou.yu@beaumont.edu

PMID: 28467873
DOI: 10.1056/NEJMc1703162

No abstract available

Publication types

Letter
Comment

MeSH terms

Anemia, Sickle Cell*
Humans